ICI 66082 is a competitive beta-blocker that lacks intrinsic sympathomimetic activity and negative inotropic action at typical doses.
No takes yet. Share an insight, caveat, or question.
Supports cardioselective beta-blockade without inotropy at typical doses in dogs; leaves open human translation.
Harry et al. (1974) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: